Pharma Industry News

Feraccru hits endpoints in anaemia trial

Oral iron replacement therapy Feraccru has been shown to have comparable efficacy to intravenously delivered Ferinject in patients with Iron Deficiency Anaemia, offering a "real" alternative to hospital administration for many patients.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]